Significance and clinical application of atrial natriuretic polypeptide as hormone and neuropeptide
Significance and clinical application of atrial natriuretic polypeptide as hormone and neuropeptide
批准号:
62570512
负责人:
NAKAO Kazuwa
金额:
$1.22万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for General Scientific Research (C)
财政年份:
1987
资助国家:
日本
项目状态:
已结题
起止时间:
1987 至 1988
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Following the isolation of atrial natriuretic polypeptide (ANP) by Matsuo et al and by de Bold et al, we prepared specific antibody for ANP and using radioimmunoassay and histochemistry, we have elucidated the physiological and pathophysiological significance of ANP as a hormone implicated in the control of body fluid and blood pressure. Since then, we have developed several monoclonal antibodies against different epitopes of ANP and also set up Northern blot hybridization analysis for ANPmRNA. Using these tools, we have investigated the biosynthesis, processing and secretion of ANP in the heart and have elucidated some characteristics of the heart as an endocrine organ. We have demonstrated the augmented expression of the ANP gene in hypertension and congestive heart failure and its significance in pathophysiology of these cardiovascular disorders. So, we have proposed that the augmented expression of the ANP gene in the diseased heart is self-compensatory response of the heart, and demonstrated that ANP administration is clinically useful for treatment of cardio-vascular disorders. As diagnostic tools, we have established highly sensitive enzyme immunoassay for ANP of which sensitivity is 100 times higher than that of radioimmunoassay for ANP.We also demonstrated that ANP is present in the central nervous system, especially in the anteroventral third ventricular region which is known to be an important area for the central control of body fluid and blood pressure, and that ANP acts as a neuropeptide in the central regulation of body fluid and cardiovascular function. Thus, ANP is implicated in the control of body fluid and blood pressure as a hormone and a neuropeptide.Based on these basic studies on ANP, our clinical application of ANP is in progress in our laboratory.
期刊论文(28)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Yoshihiko Saito et al.: "Augmented expression of atrial natriuretic polypeptide gene in ventricle of human failing heart." J. Clin. Invest.83. 298-305 (1989)
Yoshihiko Saito 等人:“心房钠尿多肽基因在人类衰竭心脏心室中的增强表达。”
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Hiroshi Itoh,et al.: Journal of Clinical Endocrinology and Metabolism. 67. 429-437 (1988)
Hiroshi Itoh 等人:临床内分泌学和代谢杂志。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Hirofumi Yasue,et al.: J.Clin.Invest.83. 46-51 (1989)
Hirofumi Yasue 等人:J.Clin.Invest.83。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Hiroshi Itoh et al.: " -atrial natriuretic polypeptide ( -ANP)-derived peptides in human plasma - co-secretion of N-terminal -ANP fragment and -ANP -" J. Clin. Endocrinol. Metab.67. 429-437 (1988)
Hiroshi Itoh 等人:“人血浆中的心房钠尿肽 (-ANP) 衍生肽 - N 末端 -ANP 片段和 -ANP 的共分泌 -”J. Clin。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 28 条
Development and analysis of model rats for diseases of endocrinology and metabolism
-
批准号:23659476
-
项目类别:Grant-in-Aid for Challenging Exploratory Research
-
资助金额:$2.33万
-
财政年份:2011
-
负责人:NAKAO Kazuwa
-
依托单位:
Physiological Function of Hormones Derived from Mesenchymal Cells and Its Failure
-
批准号:21229013
-
项目类别:Grant-in-Aid for Scientific Research (S)
-
资助金额:$135.62万
-
财政年份:2009
-
负责人:NAKAO Kazuwa
-
依托单位:
Translational research and development of novel diagnostic/therapeutic modalities for metabolic syndrome based on adipocyte endocrinology and adiposcience
-
批准号:16109007
-
项目类别:Grant-in-Aid for Scientific Research (S)
-
资助金额:$73.22万
-
财政年份:2004
-
负责人:NAKAO Kazuwa
-
依托单位:
Molecular Basis of Centrally-controled Energy Homeostasis -Focusing on Leptin Resistance-
-
批准号:13307033
-
项目类别:Grant-in-Aid for Scientific Research (A)
-
资助金额:$35.36万
-
财政年份:2001
-
负责人:NAKAO Kazuwa
-
依托单位:
Clinical implication of cardiovascular hormones
-
批准号:10307026
-
项目类别:Grant-in-Aid for Scientific Research (A).
-
资助金额:$24.83万
-
财政年份:1998
-
负责人:NAKAO Kazuwa
-
依托单位:
Molecular Study on Physiological and Clinical Significance of Adrenomedullin
-
批准号:10218204
-
项目类别:Grant-in-Aid for Scientific Research on Priority Areas
-
资助金额:$39.81万
-
财政年份:1998
-
负责人:NAKAO Kazuwa
-
依托单位:
New Animal Models Of Leaness And Obesity by Genetic Engineering and its Application to Therapy
-
批准号:09557080
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$7.3万
-
财政年份:1997
-
负责人:NAKAO Kazuwa
-
依托单位:
Molecular and Clinical Study of Cardiovascular Hormones
-
批准号:08044272
-
项目类别:Grant-in-Aid for international Scientific Research
-
资助金额:$4.8万
-
财政年份:1996
-
负责人:NAKAO Kazuwa
-
依托单位:
Development of novel mouse models deficient in vasoactive substances-Clinical implication of the natriuretic peptide family and its application to gene therapy-
-
批准号:07557072
-
项目类别:Grant-in-Aid for Scientific Research (A)
-
资助金额:$7.17万
-
财政年份:1995
-
负责人:NAKAO Kazuwa
-
依托单位:
Molecular Biology of Vasoactive Substances
-
批准号:06404037
-
项目类别:Grant-in-Aid for Scientific Research (A)
-
资助金额:$22.21万
-
财政年份:1994
-
负责人:NAKAO Kazuwa
-
依托单位:
Molecular biology of vasoactive substances
-
批准号:06044129
-
项目类别:Grant-in-Aid for international Scientific Research
-
资助金额:$2.82万
-
财政年份:1994
-
负责人:NAKAO Kazuwa
-
依托单位:
Development of a CNP related drug as a new treatment for hypertension and arteriosclerosis.
-
批准号:05557051
-
项目类别:Grant-in-Aid for Developmental Scientific Research (B)
-
资助金额:$6.34万
-
财政年份:1993
-
负责人:NAKAO Kazuwa
-
依托单位:
Development and practical use of supersensitive assays for peptides with monoclonal antibodies
-
批准号:02557112
-
项目类别:Grant-in-Aid for Developmental Scientific Research (B)
-
资助金额:$7.62万
-
财政年份:1990
-
负责人:NAKAO Kazuwa
-
依托单位:
Clinical application and elucidation of significance of natriuretic peptide family
-
批准号:01480288
-
项目类别:Grant-in-Aid for General Scientific Research (B)
-
资助金额:$4.29万
-
财政年份:1989
-
负责人:NAKAO Kazuwa
-
依托单位:
国内基金
海外基金
无脊椎动物新型受体Parathyroid hormone receptor like (PTHRL) 的鉴定及其对赤拟谷盗表皮发育的调控
-
批准号:31872970
-
项目类别:面上项目
-
资助金额:59.0万元
-
批准年份:2018
-
负责人:李斌
-
依托单位: